Variant report
Variant | esv3334814 |
---|---|
Chromosome Location | chr1:153044548-153067651 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:93)
- CpG islands (count:122)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr1:153045341-153045614 | K562 | blood: | n/a | n/a |
2 | ATF1 | chr1:153045393-153045647 | K562 | blood: | n/a | n/a |
3 | CCNT2 | chr1:153045352-153045547 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr1:153045498-153045761 | K562 | blood: | n/a | n/a |
5 | CEBPD | chr1:153045266-153045639 | K562 | blood: | n/a | n/a |
6 | CTCF | chr1:153063911-153064021 | GM12878 | blood: | n/a | n/a |
7 | CTCF | chr1:153063900-153064050 | HMEC | breast: | n/a | n/a |
8 | CTCF | chr1:153063820-153063970 | HMEC | breast: | n/a | n/a |
9 | CTCF | chr1:153063864-153064071 | MCF-7 | breast: | n/a | n/a |
10 | CTCF | chr1:153066024-153066066 | GM20000 | blood: | n/a | n/a |
11 | CTCF | chr1:153064060-153064210 | HCT-116 | colon: | n/a | n/a |
12 | CTCF | chr1:153063711-153064204 | MCF-7 | breast: | n/a | n/a |
13 | CTCF | chr1:153063909-153064013 | NHEK | skin: | n/a | n/a |
14 | CTCF | chr1:153063878-153064040 | MCF-7 | breast: | n/a | n/a |
15 | CTCF | chr1:153063890-153064040 | Hela-S3 | cervix: | n/a | n/a |
16 | CTCF | chr1:153063880-153064030 | WERI-Rb-1 | eye: | n/a | n/a |
17 | CTCF | chr1:153055710-153055745 | GM13977 | blood: | n/a | n/a |
18 | CTCF | chr1:153063880-153064030 | GM06990 | blood: | n/a | n/a |
19 | CTCF | chr1:153066360-153066458 | GM20000 | blood: | n/a | n/a |
20 | CTCF | chr1:153063920-153064070 | MCF-7 | breast: | n/a | n/a |
21 | CTCF | chr1:153063860-153064010 | HEEpiC | esophagus: | n/a | n/a |
22 | CTCF | chr1:153063926-153064004 | K562 | blood: | n/a | n/a |
23 | CTCF | chr1:153063899-153064048 | K562 | blood: | n/a | n/a |
24 | CUX1 | chr1:153060227-153060448 | K562 | blood: | n/a | n/a |
25 | E2F4 | chr1:153058721-153058766 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | EBF1 | chr1:153066002-153066258 | GM12878 | blood: | n/a | n/a |
27 | EGR1 | chr1:153059567-153059711 | GM12878 | blood: | n/a | n/a |
28 | EP300 | chr1:153060278-153060498 | K562 | blood: | n/a | n/a |
29 | EP300 | chr1:153045337-153045615 | K562 | blood: | n/a | n/a |
30 | FOS | chr1:153054315-153054649 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | FOS | chr1:153050148-153050473 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | FOS | chr1:153054228-153054679 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | FOS | chr1:153050138-153050473 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | FOS | chr1:153045530-153045570 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | FOS | chr1:153054344-153054673 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | FOS | chr1:153050115-153050471 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | FOS | chr1:153045436-153045599 | MCF10A-Er-Src | breast: | n/a | chr1:153045574-153045583 chr1:153045488-153045496 chr1:153045509-153045517 |
38 | FOS | chr1:153050017-153050475 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | GATA1 | chr1:153065980-153066554 | PBDE | blood: | n/a | n/a |
40 | GATA1 | chr1:153060130-153060616 | PBDE | blood: | n/a | n/a |
41 | GATA1 | chr1:153045339-153046558 | PBDE | blood: | n/a | chr1:153045389-153045399 chr1:153046361-153046371 chr1:153045830-153045841 chr1:153045390-153045397 chr1:153045390-153045399 |
42 | GATA2 | chr1:153045208-153046108 | K562 | blood: | n/a | chr1:153045389-153045399 chr1:153045830-153045841 chr1:153045390-153045397 chr1:153045390-153045399 |
43 | GATA2 | chr1:153045259-153045720 | K562 | blood: | n/a | chr1:153045389-153045399 chr1:153045390-153045397 chr1:153045390-153045399 |
44 | GATA3 | chr1:153060431-153060787 | MCF-7 | breast: | n/a | n/a |
45 | IRF1 | chr1:153045370-153045981 | K562 | blood: | n/a | n/a |
46 | IRF1 | chr1:153048344-153048364 | K562 | blood: | n/a | n/a |
47 | IRF1 | chr1:153059196-153059214 | K562 | blood: | n/a | n/a |
48 | IRF1 | chr1:153045297-153045649 | K562 | blood: | n/a | n/a |
49 | JUN | chr1:153045361-153045677 | K562 | blood: | n/a | chr1:153045574-153045583 chr1:153045488-153045496 chr1:153045509-153045517 |
50 | JUND | chr1:153045351-153045999 | K562 | blood: | n/a | chr1:153045574-153045583 chr1:153045488-153045496 chr1:153045509-153045517 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:153045274-153045324 | HCM | heart: | n/a |
2 | chr1:153065613-153065663 | HAEpiC | amniotic membrane: | n/a |
3 | chr1:153065613-153065663 | GM12878 | blood: | n/a |
4 | chr1:153045274-153045324 | AG04449 | skin: | fetal |
5 | chr1:153045274-153045324 | HUVEC | blood vessel: | n/a |
6 | chr1:153045274-153045324 | RPTEC | kidney: | n/a |
7 | chr1:153045274-153045324 | HepG2 | liver: | n/a |
8 | chr1:153065613-153065663 | Jurkat | blood: | n/a |
9 | chr1:153065613-153065663 | BJ | skin: | n/a |
10 | chr1:153065613-153065663 | HepG2 | liver: | n/a |
11 | chr1:153045274-153045324 | HMEC | breast: | n/a |
12 | chr1:153045274-153045324 | BE2_C | brain: | n/a |
13 | chr1:153065613-153065663 | NB4 | blood: | n/a |
14 | chr1:153045274-153045324 | AG09319 | gingival: | n/a |
15 | chr1:153065613-153065663 | AG09319 | gingival: | n/a |
16 | chr1:153065613-153065663 | AG10803 | skin: | n/a |
17 | chr1:153045274-153045324 | ProgFib | skin: | n/a |
18 | chr1:153065613-153065663 | CMK | blood: | n/a |
19 | chr1:153045274-153045324 | AoSMC | blood vessel: | n/a |
20 | chr1:153065613-153065663 | HRE | kidney: | n/a |
21 | chr1:153045274-153045324 | NH-A | brain: | n/a |
22 | chr1:153045274-153045324 | HRPEpiC | eye: | n/a |
23 | chr1:153065613-153065663 | MCF-7 | breast: | n/a |
24 | chr1:153065613-153065663 | GM12891 | blood: | n/a |
25 | chr1:153045274-153045324 | Caco-2 | colon: | n/a |
26 | chr1:153045274-153045324 | BJ | skin: | n/a |
27 | chr1:153065613-153065663 | U87 | brain: | n/a |
28 | chr1:153065613-153065663 | HCT-116 | colon: | n/a |
29 | chr1:153065613-153065663 | GM12892 | blood: | n/a |
30 | chr1:153045274-153045324 | PrEC | prostate: | n/a |
31 | chr1:153045274-153045324 | Hela-S3 | cervix: | n/a |
32 | chr1:153045274-153045324 | SK-N-SH | brain: | n/a |
33 | chr1:153045274-153045324 | GM12891 | blood: | n/a |
34 | chr1:153045274-153045324 | AG09309 | skin: | n/a |
35 | chr1:153045274-153045324 | AG10803 | skin: | n/a |
36 | chr1:153065613-153065663 | HNPCEpiC | eye: | n/a |
37 | chr1:153045274-153045324 | SAEC | small airway: | n/a |
38 | chr1:153065613-153065663 | RPTEC | kidney: | n/a |
39 | chr1:153045274-153045324 | SK-N-SH_RA | brain: | n/a |
40 | chr1:153045274-153045324 | K562 | blood: | n/a |
41 | chr1:153045274-153045324 | PFSK-1 | brain: | n/a |
42 | chr1:153065613-153065663 | K562 | blood: | n/a |
43 | chr1:153065613-153065663 | H1-hESC | embryonic stem cell: | embryo |
44 | chr1:153065613-153065663 | Caco-2 | colon: | n/a |
45 | chr1:153045274-153045324 | HIPEpiC | eye: | n/a |
46 | chr1:153065613-153065663 | PrEC | prostate: | n/a |
47 | chr1:153045274-153045324 | HPAEpiC | pulmonary alveolar: | n/a |
48 | chr1:153045274-153045324 | GM12892 | blood: | n/a |
49 | chr1:153045274-153045324 | H1-hESC | embryonic stem cell: | embryo |
50 | chr1:153045274-153045324 | HEEpiC | esophagus: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:153040069..153041954-chr1:153044290..153046075,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SPRR2B | TF binding region |
SPRR2E | TF binding region |
SPRR2B | CpG island |
SPRR2E | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553094412 | chr1:153044579-153044580 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs371456314 | chr1:153044611-153044612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541889369 | chr1:153044648-153044649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs562088693 | chr1:153044654-153044655 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189793249 | chr1:153044685-153044686 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs74432511 | chr1:153044705-153044706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs440598 | chr1:153044733-153044734 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs193161585 | chr1:153044755-153044756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs112796806 | chr1:153044773-153044774 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566477824 | chr1:153044807-153044808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532453200 | chr1:153044839-153044840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs544491198 | chr1:153044890-153044891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568795502 | chr1:153044947-153044948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs537352401 | chr1:153044976-153044977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562689473 | chr1:153044986-153044987 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs6686526 | chr1:153044996-153044997 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs426147 | chr1:153045011-153045012 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs183943998 | chr1:153045060-153045061 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs539681253 | chr1:153045088-153045089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560192275 | chr1:153045092-153045093 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs527339554 | chr1:153045095-153045096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs6689066 | chr1:153045154-153045155 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs149599065 | chr1:153045168-153045169 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12097833 | chr1:153045187-153045188 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs371547042 | chr1:153045188-153045189 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112878195 | chr1:153045189-153045190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs544612108 | chr1:153045226-153045227 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs564411932 | chr1:153045230-153045231 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs116977584 | chr1:153045251-153045252 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs111739532 | chr1:153045256-153045257 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs560265536 | chr1:153045272-153045273 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs570083982 | chr1:153045279-153045280 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs528989305 | chr1:153045287-153045288 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs549016376 | chr1:153045299-153045300 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs75237818 | chr1:153045310-153045311 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs188722745 | chr1:153045320-153045321 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs442209 | chr1:153045330-153045331 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs141964769 | chr1:153045335-153045336 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs180767969 | chr1:153045377-153045378 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs539720013 | chr1:153045410-153045411 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs1500937 | chr1:153045483-153045484 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs567011252 | chr1:153045522-153045523 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs207460440 | chr1:153045526-153045527 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs185215592 | chr1:153045534-153045535 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs189527942 | chr1:153045541-153045542 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs146291646 | chr1:153045542-153045543 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs575797343 | chr1:153045552-153045553 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs538275189 | chr1:153045583-153045584 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs11812015 | chr1:153045584-153045585 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs79883482 | chr1:153045606-153045607 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 21129771 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Osteosarcoma | 17242211 | CNVD |
Ovarian cancer | 17242211 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Schizophrenia | 18990708 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Plasma-cell dyscrasia | 16705089 | CNVD |
Myeloma | 17024118 | CNVD |
Cancer | 17060936 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Gastrointestinal cancer | 16790693 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 22522925 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:153032200-153053400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr1:153044000-153044600 | Enhancers | Esophagus | oesophagus |
3 | chr1:153044000-153045400 | Enhancers | K562 | blood |
4 | chr1:153045400-153046400 | Flanking Active TSS | K562 | blood |
5 | chr1:153046400-153046800 | Enhancers | K562 | blood |
6 | chr1:153046800-153047400 | Weak transcription | K562 | blood |
7 | chr1:153047400-153047600 | Enhancers | K562 | blood |
8 | chr1:153050200-153050800 | Enhancers | NHEK | skin |
9 | chr1:153050800-153053800 | Weak transcription | NHEK | skin |
10 | chr1:153053400-153053600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr1:153053800-153055000 | Enhancers | NHEK | skin |
12 | chr1:153054000-153054800 | Enhancers | HMEC | breast |
13 | chr1:153055200-153068400 | Weak transcription | H9 Cell Line | embryonic stem cell |
14 | chr1:153059800-153060600 | Enhancers | K562 | blood |
15 | chr1:153060600-153068200 | Weak transcription | K562 | blood |
16 | chr1:153067000-153067400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
17 | chr1:153067000-153067400 | Enhancers | NHEK | skin |
18 | chr1:153067200-153067400 | Enhancers | Hela-S3 | cervix |
19 | chr1:153067400-153067600 | Enhancers | Esophagus | oesophagus |
20 | chr1:153067400-153068400 | Weak transcription | Hela-S3 | cervix |
21 | chr1:153067400-153070200 | Weak transcription | NHEK | skin |
22 | chr1:153067400-153072000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |